CompoAtlas

Degluco

Degluco, licence 80077382: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80077382
Status
Inactive licence
Licence date
10 May 2017
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Morus alba

Source : Feuille

Extraction ratio : 10:1

Dry plant equivalent : 250 milligramme

25.0 milligrammeNot calculated
bêta-glucane

Source : Avena sativa - Graine

40.0 milligrammeNot calculated
L-carnitine

Source : L-tartrate de carnitine

30.0 milligrammeNot calculated
Vitamine C

Source : Ascorbate de calcium

20.0 milligramme120,000 µg
Panax quinquefolius

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 500 milligramme

50.0 milligrammeNot calculated
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 20:1

Dry plant equivalent : 400 milligramme

20.0 milligrammeNot calculated
Acide DL-alpha lipoÏque

Source : Acide DL-alpha-lipoÏque

60.0 milligrammeNot calculated
Gymnema sylvestre

Source : Feuille

Potency : 25.0 % Gymnemic acids

50.0 milligrammeNot calculated
Propolis

Source : Apis mellifera - sécrétion

20.0 milligrammeNot calculated
Glucomannane

Source : Amorphophallus konjac - tubercule

200.0 milligrammeNot calculated

Non-medicinal ingredients

chlorophylle, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Source of antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80077382

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line